Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-036812

Chief Commercial Officer sold 1,551 shares at an average $5.21 ($8,075)

From the SEC's structured data for this filing

Trades in this filing

Cheng Sohanya Roshan · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-06-13 Sale : show line 1 in the form −66 $5.35 $353 91,434 D
2022-06-13 Sale : show line 2 in the form −1,485 $5.20 $7,722 89,949 D
Open-market sales · 1,551 sh · avg $5.21 · $8,075
Loading xslF345X03/doc4.xml…